SCHNEIDER ELECTRIC 291.800 € (-1,68 %) 
ING GROEP N.V. 30.040 € (+0,70 %) CBI 0.141 € (+3,61 %) CSG 18.492 € (+0,05 %) BENETEAU 5.960 € (-2,45 %) BE SEMICONDUCTOR 208.000 € (-2,26 %) AALBERTS NV 42.340 € (-1,07 %) ALTAREA 98.600 € (-1,99 %) PROSUS 37.775 € (-1,36 %) SANOFI 78.280 € (-0,84 %) ETHERO 0.628 € (-5,14 %) PUBLICIS GROUPE SA 104.100 € (+1,71 %) BNP PARIBAS ACT.A 106.800 € (-0,65 %) EASE2PAY NV 0.470 € (+17,21 %) MAUREL ET PROM 8.265 € (-2,65 %) PERNOD RICARD 69.000 € (+0,85 %) NANOBIOTIX 34.140 € (-10,25 %) HEINEKEN 73.600 € (+1,63 %) DANONE 66.140 € (-0,27 %) AKZO NOBEL 60.700 € (+0,56 %) MAGNUM 17.432 € (+2,64 %) CARVOLIX 6.120 € (+0,99 %) AVANTIUM 4.865 € (0,00 %) UMG 14.750 € (+0,14 %) DASSAULT SYSTEMES 22.660 € (+1,03 %) ASML HOLDING 1 489.800 € (-1,08 %) RUBIS 33.580 € (-0,36 %) SODEXO 57.000 € (+1,33 %) EDENRED 29.940 € (+2,39 %) 
RELX 31.180 € (+1,70 %) SIDETRADE 196.400 € (-0,41 %) ADP 109.300 € (-0,18 %) TOTALENERGIES 75.980 € (-1,89 %) PHILIPS KON 23.610 € (0,00 %) STMICROELECTRONICS 42.220 € (-2,00 %) AIRBUS 202.700 € (-0,49 %) MEDINCELL 24.300 € (-2,33 %) SHELL PLC 39.775 € (-0,34 %) KENDRION 19.100 € (-2,85 %) 
ARCELORMITTAL SA 62.800 € (+0,35 %) WOLTERS KLUWER 71.700 € (+0,67 %) INPOST 15.520 € (+0,06 %) INVENTIVA 3.955 € (-1,62 %) HERMES INTL 1 580.500 € (+0,48 %) SOLUTIONS 30 SE 0.594 € (-1,98 %) IMCD 97.420 € (+2,22 %) ARKEMA 59.250 € (+0,08 %) SBM OFFSHORE 33.660 € (-2,26 %) ICADE 18.770 € (-1,11 %) AUDACIA 5.940 € (+29,13 %) VINCI 118.650 € (-0,54 %) VERALLIA 19.340 € (+0,83 %) AIR LIQUIDE 167.700 € (+0,35 %) SOCIETE GENERALE 75.640 € (-0,63 %) 2CRSI 26.460 € (-0,68 %) GENSIGHT BIOLOGICS 0.124 € (+8,01 %) INTERPARFUMS 26.940 € (+1,74 %) LECTRA 22.500 € (-0,66 %) ALSTOM 16.040 € (+0,31 %) L'OREAL 392.500 € (+1,53 %) |
28/07/2026 19:23
Exosens announces the publication of its 2026 half-yearly financial reportEXOSENS EXOSENS ANNOUNCES THE PUBLICATION OF ITS 2026 HALF-YEARLY FINANCIAL REPORTPress release, Mérignac (France), 28 July 2026 – Exosens (EXENS; FR001400Q9V2), a high-tech company specializing in mission- and performance-critical amplification, detection and imaging technologies, announces that it has filed its 2026 half-yearly financial report for the six-month period ended 30 June 2026 with the Autorité des marchés financiers (AMF). The 2026 half-yearly financial report is available on the Company’s website at the following address: www.exosens.com (Home/Investors/Regulatory information/Financial reports). *** About ExosensExosens is a high-tech company, with more than 85 years of experience in the innovation, development, manufacturing and sale of high-end electro-optical technologies in the field of amplification, detection and imaging. Today, it offers its customers detection components and solutions such as advanced cameras, neutron and gamma detectors, instrument detectors and image intensifier tubes. This allows Exosens to respond to complex issues in extremely demanding environments by offering tailor-made solutions to its customers. Thanks to its sustained investments, Exosens is internationally recognized as a major innovator in optoelectronics, with production and R&D carried out on 13 sites, in Europe and North America, and with over 2,000 employees. Exosens is listed on compartment A of Euronext Paris regulated market (Ticker: EXENS; ISIN: FR001400Q9V2). Exosens is a member of Euronext Tech Leaders segment and is also included in several indices, including SBF 120, CAC All-Tradable, CAC Mid 60, FTSE Total Cap and MSCI France Small Cap. For more information: www.exosens.com. Investor RelationsLaurent Sfaxi, l.sfaxi@exosens.com Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière